Amanote Research
Register
Sign In
Rationale for Neoadjuvant Chemotherapy in the Management of Malignant Disease
doi 10.5772/55393
Full Text
Open PDF
Abstract
Available in
full text
Date
May 22, 2013
Authors
Maurie Markman
Publisher
InTech
Related search
Neoadjuvant Chemotherapy in the Management of Advanced Ovarian Cancer and Primary Cancer of the Peritoneum: Rationale and Results
Comment On: Management of the Axilla Following Neoadjuvant Chemotherapy for Breast Cancer
British Journal of Surgery
Surgery
Incorporating Robotic Surgery Into the Management of Ovarian Cancer After Neoadjuvant Chemotherapy
International Journal of Gynecological Cancer
Gynecology
Oncology
Obstetrics
Neoadjuvant Chemotherapy in Oesophageal Adenocarcinoma
The Lancet Oncology
Oncology
Towards De-Escalation of Axillary Management After Neoadjuvant Chemotherapy in Breast Cancer
Near-Infrared Intraoperative Imaging Can Successfully Identify Malignant Pleural Mesothelioma After Neoadjuvant Chemotherapy
Molecular Imaging
Nuclear Medicine
Radiology
Molecular Medicine
Condensed Matter Physics
Imaging
Biotechnology
Biomedical Engineering
Management of Malignant Conjunctival Melanoma (Radiotherapy and Local Chemotherapy)
Acta Ophthalmologica
Medicine
Ophthalmology
Neoadjuvant Chemotherapy in the Treatment of Cervical Cancer
Neoadjuvant Chemotherapy in Breast Cancer